Kerala Health Minister Announces Infrastructure and Staffing Improvements for Kozhikode Hospitals
Kerala's Health Minister K. Muraleedharan announced plans to strengthen Government Medical College Hospital and Government General Hospital in Kozhikode through infrastructure upgrades and new staff positions following visits on June 10, 2026. The improvements include creating a Department of Reproductive Medicine, adding nursing and medical staff positions, renovating surgical facilities, and purchasing new medical equipment. The initiatives aim to address longstanding funding shortages from government insurance schemes and reduce patient overflow at the medical college hospital.
Health Minister K. Muraleedharan visited both Government Medical College Hospital (MCH) and Government General Hospital in Kozhikode on June 10, 2026, and announced a comprehensive plan to improve their operations. Key proposals include establishing a Department of Reproductive Medicine at MCH, creating additional nursing officer positions at the superspeciality block, adding a senior resident doctor post in radiotherapy, and deploying new faculty for Interventional Radiology. The plan also encompasses relocating the pediatric intensive care unit, renovating the cochlear implant operation theatre, purchasing a heart-lung machine for cardiac surgeries, and addressing infrastructure issues like water leakage and drinking water shortages. Hospital officials had previously raised concerns about government owing hundreds of crores of rupees for treatment under various insurance schemes, creating severe fund shortages. The Minister also committed to developing the beach hospital to reduce congestion at the medical college facility, with improvements to match standards at Government General Hospital, Ernakulam.
What different sources said
- The HinduCenter
Steps to improve functioning of Kozhikode MCH, general hospital
Related
Sydney Psychiatrist Retains Medical License After Sexual Assault Conviction
Gopi Ilawala, a Sydney psychiatrist convicted of sexually assaulting an intoxicated colleague in 2022, has been allowed to continue practicing medicine despite the state health regulator seeking to have his registration cancelled. The New South Wales Civil and Administrative Tribunal reprimanded him and imposed conditions rather than striking him off, citing his remorse, lack of prior convictions, and support from two senior psychiatrists. The decision raises questions about professional accountability and public protection in medical regulation.
Australia's TGA to crack down on illegal peptides; government allocates $100m for arthritis research
Australia's Therapeutic Goods Administration has announced a crackdown on illegal peptides due to a surge in imports and online advertising, designating them a priority focus area. The federal government has simultaneously committed $100 million to medical research into arthritis prevention, diagnosis, and treatment. These developments reflect growing regulatory concerns about unregulated drugs and increased investment in chronic disease research.
GLP-1 Drugs Like Ozempic May Help ADHD Symptoms, According to Patient Reports and Clinical Observations
Social media users and some patients are reporting that GLP-1 receptor agonist drugs like Ozempic appear to improve ADHD symptoms, including increased focus, reduced procrastination, and better impulse control. GLP-1s were originally developed to treat Type 2 diabetes but are being studied for various other conditions. While anecdotal reports are growing, no formal clinical trials are currently testing these drugs specifically for ADHD, and the mechanism behind any potential benefit remains unclear.